comparemela.com
Latest Breaking News On - Cheng chung wei - Page 1 : comparemela.com
GLP-1 Agonists can reduce risk of mortality, liver failure in patients with type 2 diabetes and cirrhosis
Taiwan: A recent population-based cohort study published in Clinical Gastroenterology and Hepatology has revealed multiple benefits of glucagon-like peptide-1 receptor agonist (GLP-1 RA) in patients.
Taiwan
Taipei
T-ai-pei
Chiao-tung-university
Xinzhu-xian
Cheng-chung-wei
Clin-gastroenterol-hepatol
National-yang-ming-chiao-tung-university
National-health-insurance-research-database-of-taiwan
Chii-min-hwu
National-health-insurance-research-database
Agonist-use
vimarsana © 2020. All Rights Reserved.